Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Complex Vascular Malformations
NCT01811667Phase 3Completed
- Start
- May 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in vascular malformations (VM), Lymphatic Malformation (LM), generalized lymphatic anomaly (GLA). Started May 2012; status: completed.
02
Drugs
sirolimus
03
Conditions
vascular malformations (VM)Lymphatic Malformation (LM)generalized lymphatic anomaly (GLA)
Beyond the preview
Go deeper on NCT01811667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811667.